Evidence map›Paper›PMID 29310105›Full record

ArticleVirology2018

Zika viral infection and neutralizing human antibody response in a BLT humanized mouse model.

Kimberly Schmitt, Paige Charlins, Milena Veselinovic, Lauren Kinner-Bibeau, Shuang Hu, James Curlin, Leila Remling-Mulder, Ken E Olson, Tawfik Aboellail, Ramesh Akkina

Open access · greenAbstract read
In one paragraph

Article in Virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Humanized Mice as a Tool to Study Sepsis-More Than Meets the Eye.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kimberly SchmittDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Paige CharlinsDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Milena VeselinovicDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Lauren Kinner-BibeauDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Shuang HuDepartment of Medical Microbiology & Immunology, University of California, Davis, CA 95616, USA.
James CurlinDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Leila Remling-MulderDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Ken E OlsonDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Tawfik AboellailDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Ramesh AkkinaDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA. Electronic address: akkina@colostate.edu.
Colorado State University · USUniversity of California Davis Medical Center · US

Funding

An Ultrasensitive In Vivo Latent HIV Viral Outgrowth Assay Using Humanized MiceR01AI120021 · NIAID · COLORADO STATE UNIVERSITY · PI AKKINA, RAMESH · 2015 to 2019
$3.4M
Modeling Next Generation HIV PrEP in Humanized MiceR01AI100845 · NIAID · COLORADO STATE UNIVERSITY · PI AKKINA, RAMESH · 2012 to 2014
$2.0M
NIAID NIH HHS R01 AI100845NIAID NIH HHS R01 AI120021
6 · The paper itself

Abstract

Many murine and non-human primate animal models have been recently developed to understand Zika viral pathogenesis. However, a major limitation with these models is the inability to directly examine the human-specific immune response. Here, we utilized a BLT humanized mouse model endowed with a transplanted human immune system. Plasma viremia could be detected within 48h after viral challenge and viremia persisted for as long as 220 days in some mice. Neutralizing human antibody was detected in infected mice and mouse sera showed reactivity with the viral envelope and capsid proteins in a radio-immunoprecipitation assay. Human monocytes/macrophages, B cells and hematopoietic stem cells in the bone marrow were found to be virus infected. These data establish that BLT mice are permissive for Zika viral infection and are capable of generating viral-specific human immune responses thus providing a human surrogate model for future testing of vaccine and antiviral therapeutic candidates.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralB-LymphocytesDisease Models, AnimalFemaleHematopoietic Stem CellsHumansMaleMiceMice, Inbred BALB CViremiaZika VirusZika Virus InfectionAntibodies, NeutralizingAntibodies, ViralAnimal model for Zika virusAnti-Zika viral antibodies in BLT humanized miceHu-Mouse model for Zika viral infectionImmmunoprecipitation of Zika viral proteinsNeutralizing antibodies to Zika virus in hu-miceZika Infection of human myeloid cells, B cells and HSCZika viral infection and immune response in BLT miceZika viral pathogenesis in humanized miceZika viral tropism to human cells in BLT mice

Identifiers

PMID29310105
PMCPMC5906046
OpenAlexW2781927493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.